Recent Advances in the Management of the Acute Respiratory Distress Syndrome

Clinics in Chest Medicine

Volumn 36, Issue 3, 2015, Pages 481-496

  Hager, David N ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Advances; ALI; ARDS; Driving pressure; Epidemiology; Management; Mechanical ventilation; PEEP

Indexed keywords

CISATRACURIUM; CORTICOSTEROID; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PANCURONIUM; ROCURONIUM; STEROID; VECURONIUM;

ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY PRESSURE; AIRWAY PRESSURE RELEASE VENTILATION; ARTIFICIAL VENTILATION; ATELECTASIS; BODY POSTURE; BODY WEIGHT; DISEASE SEVERITY; EARLY DIAGNOSIS; EXTRACORPOREAL OXYGENATION; FLUID BALANCE; HIGH FREQUENCY OSCILLATION; HUMAN; HYPOXEMIA; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG EDEMA; LUNG LAVAGE; MULTICENTER STUDY (TOPIC); NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; REVIEW; THORAX RADIOGRAPHY; TIDAL VOLUME; TISSUE OXYGENATION; TREATMENT OUTCOME; CELL HYPOXIA; PHYSIOLOGY; PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT;

CELL HYPOXIA; HUMANS; POSITIVE-PRESSURE RESPIRATION; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84939652303     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2015.05.002     Document Type: Review

References (117)

1. Ashbaugh D.G., Bigelow D.B., Petty T.L., et al. Acute respiratory distress in adults. Lancet 1967, 2(7511):319-323.
2. Bernard G.R., Artigas A., Brigham K.L., et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149(3 Pt 1):818-824.
3. Ferguson N.D., Kacmarek R.M., Chiche J.D., et al. Screening of ARDS patients using standardized ventilator settings: influence on enrollment in a clinical trial. Intensive Care Med 2004, 30(6):1111-1116.
4. Force A.D.T., Ranieri V.M., Rubenfeld G.D., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 2012, 307(23):2526-2533.
5. Rubenfeld G.D., Caldwell E., Peabody E., et al. Incidence and outcomes of acute lung injury. NEngl J Med 2005, 353(16):1685-1693.
6. Li G., Malinchoc M., Cartin-Ceba R., et al. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011, 183(1):59-66.
7. Hernu R., Wallet F., Thiolliere F., et al. An attempt to validate the modification of the American-European consensus definition of acute lung injury/acute respiratory distress syndrome by the Berlin definition in a university hospital. Intensive Care Med 2013, 39(12):2161-2170.
8. Caser E.B., Zandonade E., Pereira E., et al. Impact of distinct definitions of acute lung injury on its incidence and outcomes in Brazilian ICUs: prospective evaluation of 7,133 patients. Crit Care Med 2014, 42(3):574-582.
9. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. NEngl J Med 2000, 342(18):1301-1308.
10. Hager D.N., Krishnan J.A., Hayden D.L., et al. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high. Am J Respir Crit Care Med 2005, 172(10):1241-1245.
11. Fan E., Needham D.M., Stewart T.E. Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA 2005, 294(22):2889-2896.
12. Putensen C., Theuerkauf N., Zinserling J., et al. Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009, 151(8):566-576.
13. Petrucci N., Iacovelli W. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2007, (3). CD003844.
14. Petrucci N., De Feo C. Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane Database Syst Rev 2013, (2). CD003844.
15. Brower R.G., Lanken P.N., MacIntyre N., et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004, 351(4):327-336.
16. Meade M.O., Cook D.J., Guyatt G.H., et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008, 299(6):637-645.
17. Mercat A., Richard J.C., Vielle B., et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008, 299(6):646-655.
18. Briel M., Meade M., Mercat A., et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010, 303(9):865-873.
19. Grasso S., Stripoli T., De M.M., et al. ARDSnet ventilatory protocol and alveolar hyperinflation: role of positive end-expiratory pressure. Am J Respir Crit Care Med 2007, 176(8):761-767.
20. Grasso S., Fanelli V., Cafarelli A., et al. Effects of high versus low positive end-expiratory pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 2005, 171(9):1002-1008.
21. Gattinoni L., Caironi P., Cressoni M., et al. Lung recruitment in patients with the acute respiratory distress syndrome. NEngl J Med 2006, 354(17):1775-1786.
22. Nieszkowska A., Lu Q., Vieira S., et al. Incidence and regional distribution of lung overinflation during mechanical ventilation with positive end-expiratory pressure. Crit Care Med 2004, 32(7):1496-1503.
23. Amato M.B., Barbas C.S., Medeiros D.M., et al. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1995, 152(6 Pt 1):1835-1846.
24. Harris R.S., Hess D.R., Venegas J.G. An objective analysis of the pressure-volume curve in the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000, 161(2 Pt 1):432-439.
25. Amato M.B., Barbas C.S., Medeiros D.M., et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. NEngl J Med 1998, 338(6):347-354.
26. Grasso S., Terragni P., Mascia L., et al. Airway pressure-time curve profile (stress index) detects tidal recruitment/hyperinflation in experimental acute lung injury. Crit Care Med 2004, 32(4):1018-1027.
27. Ranieri V.M., Giuliani R., Fiore T., et al. Volume-pressure curve of the respiratory system predicts effects of PEEP in ARDS: "occlusion" versus "constant flow" technique. Am J Respir Crit Care Med 1994, 149(1):19-27.
28. Ranieri V.M., Zhang H., Mascia L., et al. Pressure-time curve predicts minimally injurious ventilatory strategy in an isolated rat lung model. Anesthesiology 2000, 93(5):1320-1328.
29. Milic-Emili J., Mead J., Turner J.M., et al. Improved technique for estimating pleural pressure from esophageal balloons. JAppl Physiol 1964, 19:207-211.
30. Hager D.N., Brower R.G. Customizing lung-protective mechanical ventilation strategies. Crit Care Med 2006, 34(5):1554-1555.
31. Talmor D.S., Fessler H.E. Are esophageal pressure measurements important in clinical decision-making in mechanically ventilated patients?. Respir Care 2010, 55(2):162-172. [discussion: 172-4].
32. Talmor D., Sarge T., Malhotra A., et al. Mechanical ventilation guided by esophageal pressure in acute lung injury. NEngl J Med 2008, 359(20):2095-2104.
33. Fish E., Novack V., Banner-Goodspeed V.M., et al. The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure. BMJ Open 2014, 4(9):e006356.
34. Amato M.B., Meade M.O., Slutsky A.S., et al. Driving pressure and survival in the acute respiratory distress syndrome. NEngl J Med 2015, 372(8):747-755.
35. Slutsky A.S. Mechanical ventilation. American College of Chest Physicians' Consensus Conference. Chest 1993, 104(6):1833-1859.
36. Krishnan J.A., Brower R.G. High-frequency ventilation for acute lung injury and ARDS. Chest 2000, 118(3):795-807.
37. Fort P., Farmer C., Westerman J., et al. High-frequency oscillatory ventilation for adult respiratory distress syndrome-a pilot study. Crit Care Med 1997, 25(6):937-947.
38. Mehta S., Lapinsky S.E., Hallett D.C., et al. Prospective trial of high-frequency oscillation in adults with acute respiratory distress syndrome. Crit Care Med 2001, 29(7):1360-1369.
39. Chiche J.D., Boukef R., Laurent I., et al. High frequceny oscillatory ventilation (HFOV) improves oxygenation in patients with severe ARDS. Am J Respir Crit Care Med 2000, 161:48.
40. David M., Weiler N., Heinrichs W., et al. High-frequency oscillatory ventilation in adult acute respiratory distress syndrome. Intensive Care Med 2003, 29(10):1656-1665.
41. Derdak S., Mehta S., Stewart T.E., et al. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med 2002, 166(6):801-808.
42. Fessler H.E., Derdak S., Ferguson N.D., et al. Aprotocol for high-frequency oscillatory ventilation in adults: results from a roundtable discussion. Crit Care Med 2007, 35(7):1649-1654.
43. Froese A.B. The incremental application of lung-protective high-frequency oscillatory ventilation. Am J Respir Crit Care Med 2002, 166(6):786-787.
44. Fessler H.E., Hager D.N., Brower R.G. Feasibility of very high-frequency ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2008, 36(4):1043-1048.
45. Hager D.N., Fessler H.E., Kaczka D.W., et al. Tidal volume delivery during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2007, 35(6):1522-1529.
46. Ferguson N.D., Cook D.J., Guyatt G.H., et al. High-frequency oscillation in early acute respiratory distress syndrome. NEngl J Med 2013, 368(9):795-805.
47. Young D., Lamb S.E., Shah S., et al. High-frequency oscillation for acute respiratory distress syndrome. NEngl J Med 2013, 368(9):806-813.
48. Guervilly C., Forel J.M., Hraiech S., et al. Right ventricular function during high-frequency oscillatory ventilation in adults with acute respiratory distress syndrome. Crit Care Med 2012, 40(5):1539-1545.
49. Roubik K., Rafl J., van Heerde M., et al. Design and control of a demand flow system assuring spontaneous breathing of a patient connected to an HFO ventilator. IEEE Trans Biomed Eng 2011, 58(11):3225-3233.
50. Frawley P.M., Habashi N.M. Airway pressure release ventilation: theory and practice. AACN Clin Issues 2001, 12(2):234-246.
51. Downs J.B., Stock M.C. Airway pressure release ventilation: a new concept in ventilatory support. Crit Care Med 1987, 15(5):459-461.
52. Rasanen J., Downs J.B., Stock M.C. Cardiovascular effects of conventional positive pressure ventilation and airway pressure release ventilation. Chest 1988, 93(5):911-915.
53. Wrigge H., Zinserling J., Neumann P., et al. Spontaneous breathing with airway pressure release ventilation favors ventilation in dependent lung regions and counters cyclic alveolar collapse in oleic-acid-induced lung injury: a randomized controlled computed tomography trial. Crit Care 2005, 9(6):R780-R789.
54. Putensen C., Zech S., Wrigge H., et al. Long-term effects of spontaneous breathing during ventilatory support in patients with acute lung injury. Am J Respir Crit Care Med 2001, 164(1):43-49.
55. Raoof S., Goulet K., Esan A., et al. Severe hypoxemic respiratory failure: part 2-nonventilatory strategies. Chest 2010, 137(6):1437-1448.
56. Sessler C.N. Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 2005, 33(3 Suppl):S209-S216.
57. Sessler C.N. Train-of-four to monitor neuromuscular blockade?. Chest 2004, 126(4):1018-1022.
58. Gainnier M., Roch A., Forel J.M., et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004, 32(1):113-119.
59. Forel J.M., Roch A., Marin V., et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006, 34(11):2749-2757.
60. Papazian L., Forel J.M., Gacouin A., et al. Neuromuscular blockers in early acute respiratory distress syndrome. NEngl J Med 2010, 363(12):1107-1116.
61. Prielipp R.C., Coursin D.B., Scuderi P.E., et al. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995, 81(1):3-12.
62. Hansen-Flaschen J., Cowen J., Raps E.C. Neuromuscular blockade in the intensive care unit. More than we bargained for. Am Rev Respir Dis 1993, 147(1):234-236.
63. Mutoh T., Guest R.J., Lamm W.J., et al. Prone position alters the effect of volume overload on regional pleural pressures and improves hypoxemia in pigs invivo. Am Rev Respir Dis 1992, 146(2):300-306.
64. Lamm W.J., Graham M.M., Albert R.K. Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 1994, 150(1):184-193.
65. Broccard A., Shapiro R.S., Schmitz L.L., et al. Prone positioning attenuates and redistributes ventilator-induced lung injury in dogs. Crit Care Med 2000, 28(2):295-303.
66. Gattinoni L., Tognoni G., Pesenti A., et al. Effect of prone positioning on the survival of patients with acute respiratory failure. NEngl J Med 2001, 345(8):568-573.
67. Mancebo J., Fernandez R., Blanch L., et al. Amulticenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome. Am J Respir Crit Care Med 2006, 173(11):1233-1239.
68. Guerin C., Reignier J., Richard J.C., et al. Prone positioning in severe acute respiratory distress syndrome. NEngl J Med 2013, 368(23):2159-2168.
69. Geer R.T., Soma L.R., Barnes C., et al. Effects of albumin and/or furosemide therapy on pulmonary edema induced by hydrochloric acid aspiration in rabbits. JTrauma 1976, 16(10):788-791.
70. Ali J., Chernicki W., Wood L.D. Effect of furosemide in canine low-pressure pulmonary edema. JClin Invest 1979, 64(5):1494-1504.
71. Reising C.A., Chendrasekhar A., Wall P.L., et al. Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS). JSurg Res 1999, 82(1):56-60.
72. Simmons R.S., Berdine G.G., Seidenfeld J.J., et al. Fluid balance and the adult respiratory distress syndrome. Am Rev Respir Dis 1987, 135(4):924-929.
73. Schuster D.P. The case for and against fluid restriction and occlusion pressure reduction in adult respiratory distress syndrome. New Horiz 1993, 1(4):478-488.
74. Humphrey H., Hall J., Sznajder I., et al. Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 1990, 97(5):1176-1180.
75. Mitchell J.P., Schuller D., Calandrino F.S., et al. Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis 1992, 145(5):990-998.
76. Martin G.S., Mangialardi R.J., Wheeler A.P., et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002, 30(10):2175-2182.
77. Grissom C.K., Hirshberg E.L., Dickerson J.B., et al. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome. Crit Care Med 2015, 43(2):288-295.
78. Mikkelsen M.E., Christie J.D., Lanken P.N., et al. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012, 185(12):1307-1315.
79. Barnett N., Ware L.B. Biomarkers in acute lung injury-marking forward progress. Crit Care Clin 2011, 27(3):661-683.
80. Ware L.B., Koyama T., Billheimer D.D., et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137(2):288-296.
81. Thompson B.T. Corticosteroids for ARDS. Minerva Anestesiol 2010, 76(6):441-447.
82. Thompson B.T. Glucocorticoids and acute lung injury. Crit Care Med 2003, 31(4 Suppl):S253-S257.
83. Weigelt J.A., Norcross J.F., Borman K.R., et al. Early steroid therapy for respiratory failure. Arch Surg 1985, 120(5):536-540.
84. Schein R.M., Bergman R., Marcial E.H., et al. Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome. Chest 1987, 91(6):850-854.
85. Luce J.M., Montgomery A.B., Marks J.D., et al. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138(1):62-68.
86. Bone R.C., Fisher C.J., Clemmer T.P., et al. Acontrolled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. NEngl J Med 1987, 317(11):653-658.
87. Bernard G.R., Luce J.M., Sprung C.L., et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. NEngl J Med 1987, 317(25):1565-1570.
88. Confalonieri M., Urbino R., Potena A., et al. Hydrocortisone infusion for severe community-acquired pneumonia - a preliminary randomized study. Am J Respir Crit Care Med 2005, 171(3):242-248.
89. Annane D., Sebille V., Bellissant E. Ger-Inf-05 Study G: effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006, 34(1):22-30.
90. Meduri G.U., Headley A.S., Golden E., et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280(2):159-165.
91. Steinberg K.P., Hudson L.D., Goodman R.B., et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. NEngl J Med 2006, 354(16):1671-1684.
92. Taylor R.W., Zimmerman J.L., Dellinger R.P., et al. Inhaled nitric oxide in ASG: low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004, 291(13):1603-1609.
93. Dellinger R.P., Zimmerman J.L., Taylor R.W., et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998, 26(1):15-23.
94. Rossaint R., Falke K.J., Lopez F., et al. Inhaled nitric oxide for the adult respiratory distress syndrome. NEngl J Med 1993, 328(6):399-405.
95. Michael J.R., Barton R.G., Saffle J.R., et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1372-1380.
96. Troncy E., Collet J.P., Shapiro S., et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1483-1488.
97. Lundin S., Mang H., Smithies M., et al. Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999, 25(9):911-919.
98. Torbic H., Szumita P.M., Anger K.E., et al. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. JCrit Care 2013, 28(5):844-848.
99. McAuley D.F., Laffey J.G., O'Kane C.M., et al. Simvastatin in the acute respiratory distress syndrome. NEngl J Med 2014, 371(18):1695-1703.
100. National Heart L., Blood Institute A.C.T.N., Truwit J.D., et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. NEngl J Med 2014, 370(23):2191-2200.
101. Jacobson J.R., Barnard J.W., Grigoryev D.N., et al. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2005, 288(6):L1026-L1032.
102. Shyamsundar M., McKeown S.T., O'Kane C.M., et al. Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med 2009, 179(12):1107-1114.
103. Zapol W.M., Snider M.T., Hill J.D., et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979, 242(20):2193-2196.
104. Gattinoni L., Pesenti A., Mascheroni D., et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986, 256(7):881-886.
105. Morris A.H., Wallace C.J., Menlove R.L., et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994, 149(2 Pt 1):295-305.
106. Brodie D., Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. NEngl J Med 2011, 365(20):1905-1914.
107. Peek G.J., Mugford M., Tiruvoipati R., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363.
108. Combes A. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome (EOLIA). Available at: . Accessed April 05, 2015. https://clinicaltrials.gov/ct2/show/NCT01470703.
109. Gajic O., Frutos-Vivar F., Esteban A., et al. Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients. Intensive Care Med 2005, 31(7):922-926.
110. Michelet P., D'Journo X.B., Roch A., et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology 2006, 105(5):911-919.
111. Determann R.M., Royakkers A., Wolthuis E.K., et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care 2010, 14(1):R1.
112. Serpa Neto A., Cardoso S.O., Manetta J.A., et al. Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis. JAMA 2012, 308(16):1651-1659.
113. Gajic O., Rana R., Winters J.L., et al. Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med 2007, 176(9):886-891.
114. Gajic O., Yilmaz M., Iscimen R., et al. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med 2007, 35(7):1645-1648.
115. Kor D.J., Talmor D.S., Banner-Goodspeed V.M., US Critical Illness and Injury Trials Group, Lung Injury Prevention with Aspirin Study Group (USCIITG:LIPS-A), et al. Lung Injury Prevention with Aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open 2012, 2(5). [pii:e001606].
116. Levitt J.E., Calfee C.S., Goldstein B.A., et al. Early acute lung injury: criteria for identifying lung injury prior to the need for positive pressure ventilation. Crit Care Med 2013, 41(8):1929-1937.
117. Gajic O., Dabbagh O., Park P.K., et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011, 183(4):462-470.